JNK and p53 cause human and mouse β cell death during excessive unfolded protein response
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci193035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Rohit B Sharma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism and the Joan and Sanford I. Weill Center for Metabolic Health, Weill Cornell Medicine, New York, N…. Hauptthemen laut MEDLINE: Unfolded Protein Response, Insulin-Secreting Cells, Tumor Suppressor Protein p53, Apoptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH/NIDDK.
Abstract (Originalsprache)
Endoplasmic reticulum (ER) stress contributes to β cell death in both Type 1 and Type 2 diabetes (T1D and T2D). However, the molecular mechanisms driving β cell death during ER stress remain insufficiently defined, limiting development of protective therapies. GRP78, an ER chaperone, is the master regulator of unfolded protein response (UPR), suppressing UPR initiators during the unstressed state and releasing them to allow UPR activation during stress. To dissect the pathways leading to ER-stress response related β cell decompensation, we engineered mice genetically lacking GRP78 in pancreatic β cells. GRP78 deletion caused acute insulin-deficient diabetes in pups before weaning, with reduced β cell mass due to increased apoptosis. Molecular studies identified deregulated UPR, specifically IRE1 activity, as driving cell death. Unbiased and targeted analyses identified a JNK-p53 axis downstream of IRE1 kinase as a key mediator of β cell death during UPR activation. In vivo JNK inhibition protected against β cell death in 2 distinct ER stress diabetes models. In human β cells, pharmacological inhibition of both JNK and p53 improved β cell survival during GRP78 knockdown–induced UPR. These findings provide insight into mechanisms causing β cell death during ER stress and outline possible therapeutic targets to preserve insulin secretory capacity in diabetes. This study identifies JNK and p53 as mediators of pancreatic beta cell death during ER stress, which could lead beta cell preserving therapies for diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism and the Joan and Sanford I. Weill Center for Metabolic Health, Weill Cornell Medicine, New York, New York, USA.
- Diabetes Division, UMASS Chan Medical School, Worcester, Massachusetts, USA.
- Ansary Stem Cell Institute, Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
- Program in Molecular Medicine, UMASS Chan Medical School, Worcester, Massachusetts, USA.
- Basic Science and Cancer Research, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Förderung
- NIDDK NIH HHS
- NIH/NIDDK
Zitieren
APA
Sharma, R. B., Darko, C., Wang, Y., Castro, T. A., Lama, T. D., Gablaski, B., Rappa, A., Redmond, D., Kim, J. K., Lee, A. S., & Alonso, L. C. (2026). JNK and p53 cause human and mouse β cell death during excessive unfolded protein response. Journal of Clinical Investigation. https://doi.org/10.1172/jci193035
Vancouver
Sharma RB, Darko C, Wang Y, Castro TA, Lama TD, Gablaski B, et al. JNK and p53 cause human and mouse β cell death during excessive unfolded protein response. Journal of Clinical Investigation. 2026. doi:10.1172/jci193035
BibTeX
@article{Sharma2026,
author = {Sharma, Rohit B and Darko, Christine and Wang, Ying and Castro, Thalia A and Lama, Tara Doma and Gablaski, Brian and Rappa, Andrew and Redmond, David and Kim, Jason K and Lee, Amy S and Alonso, Laura C},
title = {JNK and p53 cause human and mouse β cell death during excessive unfolded protein response},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci193035}
}
EUVIMED